Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4455429
Max Phase: Preclinical
Molecular Formula: C43H48N10O7
Molecular Weight: 816.92
Molecule Type: Unknown
Associated Items:
ID: ALA4455429
Max Phase: Preclinical
Molecular Formula: C43H48N10O7
Molecular Weight: 816.92
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(CCCCCC(=O)Nc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)cn3)nc2n(C2CCCC2)c1=O
Standard InChI: InChI=1S/C43H48N10O7/c1-25-30-24-45-43(49-38(30)52(27-9-5-6-10-27)41(59)36(25)26(2)54)47-33-16-14-28(23-44-33)51-21-19-50(20-22-51)18-7-3-4-13-34(55)46-31-12-8-11-29-37(31)42(60)53(40(29)58)32-15-17-35(56)48-39(32)57/h8,11-12,14,16,23-24,27,32H,3-7,9-10,13,15,17-22H2,1-2H3,(H,46,55)(H,48,56,57)(H,44,45,47,49)
Standard InChI Key: HJEZCPKGRBNZSZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 816.92 | Molecular Weight (Monoisotopic): 816.3707 | AlogP: 4.28 | #Rotatable Bonds: 13 |
Polar Surface Area: 208.90 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.14 | CX Basic pKa: 8.34 | CX LogP: 4.17 | CX LogD: 3.19 |
Aromatic Rings: 4 | Heavy Atoms: 60 | QED Weighted: 0.10 | Np Likeness Score: -1.00 |
1. Rana S, Bendjennat M, Kour S, King HM, Kizhake S, Zahid M, Natarajan A.. (2019) Selective degradation of CDK6 by a palbociclib based PROTAC., 29 (11): [PMID:30935795] [10.1016/j.bmcl.2019.03.035] |
Source(1):